FIGO 3型子宫肌瘤宫腔镜治疗的术中定位与分步手术技术
视频文章报道2例FIGO 3型肌瘤患者,采用术前超声测量联合术中剪刀尖端标记定位、分步宫腔镜切除技术,无需术中超声引导。两例均单次手术完整切除肌瘤,保留周围内膜,术后超声示内膜回声连续、无宫腔粘连;例1异常出血缓解并自然妊娠,例2胚胎移植后临床妊娠。
要点
- 术前经阴道超声测量肌瘤中心至宫颈内口、宫底及宫腔中线的距离用于定位。
- 术中剪刀尖端标记后,依次切开内膜与假包膜、镜体剥离、缩宫素促突出、双极环或冷钳切除。
- 该技术可精准定位并减少内膜损伤,可能改善月经过多及不孕患者生殖结局。
核心结论
- 术前超声测量联合术中剪刀尖端标记的定位方法,配合分步宫腔镜手术,治疗FIGO 3型肌瘤可行且有效。
- 该技术有助于精准定位并降低子宫内膜损伤风险。
- 宫腔镜治疗FIGO 3型肌瘤可改善月经过多症状,并可能改善不明原因反复种植失败不孕患者的生殖结局。
研究设计与样本
- 视频文章,报道2例在北京大学第三医院接受宫腔镜手术的FIGO 3型肌瘤患者。
- 例1为34岁女性,月经过多及不明原因不孕,肌瘤直径2.5 cm。
- 例2为35岁不孕女性,反复种植失败,肌瘤直径<1 cm。
主要发现
- 两例FIGO 3型肌瘤均在无术中超声引导下定位,并单次手术完整切除,未切除肌瘤周围内膜。
- 两例术后经阴道超声均显示内膜回声连续,无宫腔粘连征象。
- 例1术后异常子宫出血完全缓解,术后3个月自然妊娠。
- 例2移植两枚新鲜卵裂期胚胎,术后2个月临床宫内妊娠。
关键数值与推荐
- 术前在矢状面测量肌瘤中心至宫颈内口及内膜宫底的距离,在横断面测量肌瘤中心至宫腔中线的距离。
- 术中先用剪刀切开肌瘤表面内膜及假包膜暴露肌瘤,再用镜体将肌瘤从假包膜剥离。
- 静脉给予缩宫素促进肌层收缩使肌瘤逐渐突入宫腔,最后用双极环或冷钳切除肌瘤。
- 术后1至3个月随访经阴道超声确认目标肌瘤消失。
临床怎么用
- 对FIGO 3型肌瘤可尝试术前超声测量联合术中剪刀尖端标记定位,减少对术中超声引导的依赖。
- 分步手术中利用缩宫素促肌瘤突入宫腔,有助于保护周围内膜。
- 术后需经阴道超声随访内膜连续性及有无宫腔粘连。
局限性
- 本文为视频文章,仅报道2例患者,样本量有限。
- 术后生殖结局的长期随访数据仍在收集,尚未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To present an intraoperative localization method and a stepwise surgical technique for hysteroscopic treatment of International Federation of Gynecology and Obstetrics (FIGO) type 3 fibroid without ultrasound guidance. DESIGN: Video article. SUBJECTS: Case 1 is a 34-year-old woman with complaints of menorrhagia and unexplained infertility and a FIGO type 3 myoma measuring 2.5 cm in diameter. Case 2 is a 35-year-old infertile woman with recurrent implantation failure and a FIGO type 3 myoma measuring <1 cm in diameter. Both women underwent hysteroscopic surgery at Peking University Third Hospital. EXPOSURE: Preoperative localization was performed by the surgeon using transvaginal ultrasound to measure the distance from the fibroid center to the internal cervical os and the endometrial fundus on sagittal plane, and the distance from the fibroid center to the uterine cavity midline on the transverse plane. Intraoperative marking was then performed using hysteroscopic scissors, ensuring precise visualization and resection guidance. The fibroid was resected using the following stepwise technique: 1) the endometrium and pseudocapsule overlying the fibroid were incised with scissors to expose the myoma, 2) the fibroid was detached from the pseudocapsule using the body of the hysteroscope, 3) intravenous oxytocin was administered to promote myometrial contraction, facilitating the fibroid's gradual protrusion into the uterine cavity, and 4) the fibroid was resected using bipolar loop or cold forceps. MAIN OUTCOME MEASURES: Complete resection of the FIGO type 3 fibroid as demonstrated by the absence of the targeted myoma. This was confirmed by immediate post-procedure hysteroscopic inspection and follow-up transvaginal ultrasound conducted 1 to 3 months postoperatively. RESULTS: The FIGO type 3 fibroids were located without intraoperative ultrasound guidance, and were removed completely during a single surgery without excision of the endometrium surrounding the myoma. Postoperative transvaginal ultrasound in both patients revealed a continuous endometrial echo and no signs of intrauterine adhesions. In case 1, the patient subsequently reported complete resolution of her abnormal uterine bleeding, and she conceived spontaneously 3 months postoperatively. In case 2, the patient underwent transfer of two fresh cleavage-stage embryos and reported a clinical intrauterine pregnancy two months postoperatively. CONCLUSION: We concluded that the intraoperative localization method, which includes preoperative ultrasound measurement with intraoperative scissors-tip marking, and is followed by a stepwise surgical technique for hysteroscopic treatment of FIGO type 3 myoma, is feasible and effective. This technique offers valuable benefits for precise localization and minimization of risk of damage to the endometrium. Hysteroscopic treatment of FIGO type 3 fibroids can improve symptoms of menorrhagia and also may improve reproductive outcomes in infertile patients with unexplained recurrent implantation failure. This technique was applied in clinical practice since June 2025 and both patients were from a larger cohort of infertile women with FIGO type 3 fibroid. Long-term follow-up data regarding postoperative reproductive outcomes currently are being collected and will be presented in future reports.
引用
- Liu D, Guo Y, Fan Z, et al. An intraoperative localization method and a stepwise surgical technique for hysteroscopic treatment of International Federation of Gynecology and Obstetrics type 3 fibroid. Fertil Steril. 2026. PMID: 41679418. doi:10.1016/j.fertnstert.2026.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。